Zuuka secures funding for its wearable insulin delivery platform

New Zealand‑based startup Zuuka announced a capital raise. The funds will support development of its wearable insulin delivery platform. The technology aims to simplify diabetes management for patients. Zuuka plans to integrate continuous glucose monitoring with automated dosing. Investors see potential for improved adherence and quality of life. The company intends to conduct clinical trials later this year. Regulatory approval pathways are being mapped out as part of the rollout plan. Success could influence broader adoption of wearable medical devices.